Related Experiment Video
Updated: Oct 30, 2025
05:41
Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
Published on: February 9, 2024
819
Subclinical hypothyroidism in children: updates for pediatricians
Kotb Abbass Metwalley1, Hekma Saad Farghaly1
1Department of Pediatrics, Faculty of Medicine, Assiut University, Assiut, Egypt.
Annals of Pediatric Endocrinology & Metabolism
|July 5, 2021
Summary
Subclinical hypothyroidism (SH) in children involves elevated thyroid-stimulating hormone (TSH) with normal free T4. Management of mild SH requires individualized consideration, unlike severe cases with clear treatment guidelines.
Area of Science:
- Pediatric Endocrinology
- Thyroid Disorders
- Clinical Medicine
Background:
- Subclinical hypothyroidism (SH) is characterized by elevated serum TSH with normal free T4.
- SH is categorized as mild (TSH 4.5-10 mIU/L) or severe (TSH >10 mIU/L).
- Treatment consensus exists for severe SH in children, but mild SH management remains uncertain.
Purpose of the Study:
- To provide an updated review of subclinical hypothyroidism in pediatric populations.
- To consolidate information on SH prevalence, etiology, clinical presentation, and consequences.
- To outline current diagnostic and therapeutic strategies for pediatric SH.
Main Methods:
- Extensive literature review.
- Analysis of long-standing clinical experience.
- Synthesis of data on SH in children.
Main Results:
- Prevalence, causes, and clinical manifestations of pediatric SH are detailed.
- Consequences of untreated SH in children are discussed.
- Current therapeutic approaches for SH in children are presented.
Conclusions:
- Management of mild SH in children should be individualized.
- Pediatricians require updated information on this evolving condition.
- Further research may clarify optimal management strategies for mild SH.
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
6.0K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
6.0K
01:18Functions of Thyroid Hormones
3.9K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
3.9K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
48
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
48
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
48
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
50
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
50
01:29Drug Dosing: Infants and Children
63
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
63